Methods: OPA, using the Langham Ocular Blood Flow (OBF) System, applanation intraocular pressure (lOP), systemic blood pressure and heart rate were measured and vasospasm was determined by a fingernail capillary blood flow test.
Quigley et al. 5 did not find a reduction in the number of blood vessels in the optic nerve head region whereas Schwartz6 using fluorescein angiogra phy showed filling defects in this area in glaucoma tous subjects. These findings suggest a connection between LTG and vascular abnormalities. OPA is an indirect measure of choroidal perfusion. A bolus of blood entering the eye corresponding to the cardiac pulse is reflected in a change in lOP as a function of time. The Langham Ocular Blood Flow (OBF) System (OBF Labs, Wiltshire, UK) is a highly sensitive pneumotonometer linked to a data acquisi tion unit that measures lOP (mmHg) non-invasively with a collection rate of 200 Hz, allowing accurate measurements of OPA with minimal disturbance to
Ocular pulse amplitudes of low tension glaucoma (L TG) patients (hatched columns) with (L TG-V, n = 17) and without (LTG-NV, n = 15) a vasospastic reaction, compared with respective matched control subgroups (grey columns). Bars represent mean ± SEM. *p<O.05 compared with control eye measurements using a two-tailed, unpaired t-test.
the eye. OPA may have potential to evaluate some characteristics of OBF in a clinical setting. However, OBF was not calculated from OPA measurements because extraocular factors are involved (e.g. pulse rate, posture) and, in our opinion, the underlying assumptions and the software provided with the OBF system are not adequately documented to calculate the true absolute OBF from the pulse data. In addition to pneumotonometric values, lOP was measured by Goldmann applanation tonometry. Brachial artery pressures and heart rate (HR) were measured using a blood pressure cuff and a stetho scope. Applanation lOP, blood pressure (BP) and HR were taken before OPA measurements.
A nailfold capillary blood test was performed in all patients/volunteers. A person was considered 'vaso spastic' when blood flow cessation in the nailfold capillaries after cold water provocation was> 12 s as measured by video-capillaroscopy. 9 All measure ments were taken with the patients and volunteers in supine position.
Statistics
All data represent arithmetic mean ± standard error of the mean (SEM). Student's unpaired two-tailed t test was used for statistical analysis. Measurements were performed on both eyes of each subject. The level of significance was 5%, i.e. p<0.05 was considered significant. LTG subtypes with vasospasm (LTG-V) and without vasospasm (LTG-NV) were compared with matched subgroups from a pool of healthy volunteers and with each other.
RESULTS
OPA (mmHg) in the LTG patients with a vasospastic reaction (LTG-V, 1.4 ± 0.1, n = 17) was not significantly (p>0.09) different when compared with non-vasospastic LTG patients (LTG-NV, 1.5 ± 0.2, (Fig. 1) .
lOP (mmHg) in LTG-V (13.3 ± 0.4) and LTG-NV (13.2 ± O.S) patient groups was not significantly (p>O.OS) different when compared with each other but was significantly (p<O.OS) lower when compared with matched healthy control subgroups (IS.0 ± 0.3 and IS.2 ± 0.4, respectively) (Fig. 2) . may not favour the ophthalmic circulation. A negative effect on progression of nerve fibre layer degeneration in LTG patients who are on nitrates for other disorders is conceivable.
Nifedipine, a calcium channel blocker, is mainly an arterial vasodilator and systemic antihypertensive agent used in vasospastic diseases. This agent could be beneficial in those LTG patients with vasospastic reaction, but not those who are normal with respect to the fingernail test. Gaspar et al. 8 found an improvement in visual fields by 1.2 dB in 59 patients with visual field defects following application of nifedipine and Kitazawa 13 demonstrated visual field improvements in 6 of 25 LTG patients following application of the same drug. Lumme et al. 29 found that nifedipine has no influence on progression of optic nerve head cupping while N etland et az. 3° observed a significant decrease in the progression of LTG but not in POAG with elevated lOP over a 3.4-year period. These findings could be related to improving the reduced choroidal perfusion in these patients and thus improved nourishment to and removal of potential toxic waste products from the retinal pigment epithelium and the adjacent non vascularised outer layers of the retina, macula and optic disc regions in LTG patients.
